Kevin Ellich analyst

Currently out of the existing stock ratings of Kevin Ellich, 15 are a BUY (34.88%), 24 are a HOLD (55.81%), 4 are a SELL (9.3%).

Kevin Ellich

Work Performance Price Targets & Ratings Chart

Analyst Kevin Ellich, carries an average stock price target met ratio of 100% that have a potential upside of 14.66% achieved within 333 days. Previously, Kevin Ellich worked at CRAIG HALLUM, PIPER SANDLER.

Kevin Ellich’s has documented 106 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on AMED, Amedisys at 31-Oct-2019.

Wall Street Analyst Kevin Ellich

Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for PETS (PETMED EXPRESS) at 10/17/2019. The price target of $20 was fulfilled within 4 days with a profit of $3.63 (22.17%) receiving and performance score of 55.44.

Average potential price target upside

AMED Amedisys PETS PetMed Express ZTS Zoetis HSIC Henry Schein LH Laboratory of America Holdings LHCG LHC Group NEOG Neogen TRUP Trupanion DGX Quest Diagnostics EHC Encompass Health Corp EXAS EXACT Sciences IDXX IDEXX Laboratories

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$100

$-0.99 (-0.98%)

$100

5 months 26 days ago
(16-Apr-2025)

2/3 (66.67%)

$8.09 (8.80%)

307

Hold

$101

$0.01 (0.01%)

$103

7 months 8 days ago
(03-Mar-2025)

4/11 (36.36%)

$8.9 (9.66%)

18

Hold

$101

$0.01 (0.01%)

$165

1 years 2 months 11 days ago
(31-Jul-2024)

3/9 (33.33%)

$2.95 (3.01%)

70

Hold

$101

$0.01 (0.01%)

$101

1 years 2 months 17 days ago
(25-Jul-2024)

2/7 (28.57%)

$3.25 (3.32%)

419

Hold

1 years 6 months 16 days ago
(26-Mar-2024)

5/9 (55.56%)

$12.13 (9.49%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Kevin Ellich?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?